Latest News by Industry
NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov 15, 2024--
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:
Craig-Hallum 15 th Annual Alpha Select Conference (Sheraton New York Times Square Hotel)
November 19, 2024
1x1 Meetings Only
BTIG 4 th Annual Ophthalmology Day (Virtual)
December 2, 2024
1x1 Virtual Meetings Only
Piper Sandler 36 th Annual Healthcare Conference (The Lotte New York Palace)
December 3-5, 2024
Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024
The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company’s website.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241115031085/en/
CONTACT: Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737
KEYWORD: UNITED STATES NORTH AMERICA TENNESSEE
INDUSTRY KEYWORD: MEDICAL DEVICES SURGERY MEDICAL SUPPLIES FDA CLINICAL TRIALS OTHER HEALTH BIOTECHNOLOGY PHARMACEUTICAL HEALTH OPTICAL
SOURCE: Harrow, Inc.
Copyright Business Wire 2024.
PUB: 11/15/2024 07:00 AM/DISC: 11/15/2024 07:01 AM
http://www.businesswire.com/news/home/20241115031085/en